Admission to trading application
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK - 17 June 2026: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces that application has been made to the London Stock Exchange for the admission to trading of 122,901 ordinary shares of 50 pence each in the Company (the "New Ordinary Shares").
The requested admission relates to ordinary shares which have been alloted under:
- OXB Long Term Incentive Plan (LTIP)
- OXB Deferred Bonus Plan (DBP)
- OXB Sharesave Scheme (SAYE)
- OXB Employee Share Option Scheme (ESOS)
It is expected that admission becomes effective on 22 June 2026. The New Ordinary Shares will rank pari passu in all respects with the Company's existing ordinary shares in issue.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.